Eli Lilly & Co. said Thursday it plans to withdraw its cancer drug Lartruvo from the market after a study showed that it failed to prolong overall survival in a clinical trial.
The company will establish an access program to allow some patients with soft-tissue sarcoma—a cancer that develops in connective tissue including muscle—to continue taking the drug with limited interruption after it’s withdrawn from the market. Lilly didn’t provide a specific timeline and said it’s working with health regulators on its plans.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gettleman: Giants Won't Force A Quarterback In Round OneDespite characterizing this year's quarterbacks class as 'thick,' Giants general manager isn't about to let the court of public opinion sway his decision regarding drafting Eli Manning's successor. I won’t force myself to boo at Eli, it will happen organically
Source: Forbes - 🏆 394. / 53 Read more »
Gettleman: Giants Won't Force A Quarterback In NFL Draft's First RoundDespite characterizing this year's quarterbacks class as 'thick,' Giants general manager isn't about to let the court of public opinion sway his decision regarding drafting Eli Manning's successor. This Gettlemen doesn't know which way the winds blows when it hits him in the face. Cowboys own the Giants! CowboysNation “Won’t Force” what a choice of words?
Source: Forbes - 🏆 394. / 53 Read more »